Pharmacovigilance analysis of peripheral neuropathy with newer generation proteasome inhibitors: Using the FDA Adverse Event Reporting System (FAERS)

被引：0
|
作者：
Mina, S. A. [1 ]
Muhsen, I. N. [2 ]
Burns, E. A. [2 ]
Sarfaraz, H. [2 ]
Xu, J. [3 ]
Hashmi, S. K. [4 ]
机构：
[1] Mayo Clin, Dept Internal Med, Phoenix, AZ USA
[2] Houston Methodist, Dept Internal Med, Houston, TX USA
[3] Houston Methodist Res Inst, Houston Methodist DeBakey Heart & Vasc Ctr, Ctr Outcomes Res, Houston, TX USA
[4] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-PO
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [1] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [2] Post-Marketing Analysis of Peripheral Neuropathy Burden with New-Generation Proteasome Inhibitors Using the FDA Adverse Event Reporting System
    Mina, Syeda A.
    Muhsen, Ibrahim N.
    Burns, Ethan A.
    Sarfaraz, Humaira
    Pingali, Sai Ravi
    Xu, Jiaqiong
    Hashmi, Shahrukh K.
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (03) : 218 - 221
  • [3] Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Sun, Ximu
    Zhou, Han
    Li, Yanming
    Luo, Yanhui
    Guo, Qixiang
    Sun, Yixin
    Jia, Chenguang
    Wang, Bin
    Qin, Maoquan
    Guo, Peng
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 11 (01)
  • [4] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
  • [5] Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Zhou, Chaozheng
    Peng, Shengkun
    Lin, Anqi
    Jiang, Aimin
    Peng, Yuanxi
    Gu, Tianqi
    Liu, Zaoqu
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    ECLINICALMEDICINE, 2023, 59
  • [6] Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
    Zhou, Jianxing
    Wei, Zipeng
    Xu, Baohua
    Liu, Maobai
    Xu, Ruichao
    Wu, Xuemei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
    Ma, Zhuo
    Pei, Jie
    Sun, Ximu
    Liu, Lihong
    Lu, Wenchao
    Guo, Qixiang
    Lyu, Jiayou
    Liu, Yuwei
    Zhang, Yuhui
    Zhao, Zhixia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Chengwen Teng
    Christopher R. Frei
    Drugs - Real World Outcomes, 2022, 9 : 23 - 29
  • [9] Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Baus, Courtney
    Wilson, James P.
    Frei, Christopher R.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (11): : 1504 - 1509
  • [10] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Frei, Christopher R.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 23 - 29
12345